Effects of glucagon‐like peptide‐1 on the differentiation and metabolism of human adipocytes

BACKGROUND AND PURPOSE: Glucagon‐like peptide‐1 (GLP‐1) analogues improve glycaemic control in type 2 diabetic (T2D) patients and cause weight loss in obese subjects by as yet unknown mechanisms. We recently demonstrated that the GLP‐1 receptor, which is present in adipocytes and the stromal vascula...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Pharmacol
Main Authors: El Bekay, Rajaa, Coín‐Aragüez, Leticia, Fernández‐García, Diego, Oliva‐Olivera, Wilfredo, Bernal‐López, Rosa, Clemente‐Postigo, Mercedes, Delgado‐Lista, Javier, Diaz‐Ruiz, Alberto, Guzman‐Ruiz, Rocío, Vázquez‐Martínez, Rafael, Lhamyani, Said, Roca‐Rodríguez, María Mar, Veledo, Sonia Fernandez, Vendrell, Joan, Malagón, María M., Tinahones, Francisco José
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2016
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4867741/
https://ncbi.nlm.nih.gov/pubmed/26993859
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13481
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados